Sequana Medical NV, a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, announces that it received transparency notifications from the shareholders listed below, notifying the number of voting rights attached to shares mentioned next to their respective names in the table below.
January 24, 2024
· 6 min read